GSIIX
Price
$47.08
Change
-$0.86 (-1.79%)
Updated
May 21 closing price
Net Assets
399.64M
RMFCX
Price
$56.15
Change
-$0.84 (-1.47%)
Updated
May 21 closing price
Net Assets
104.75B
Interact to see
Advertisement

GSIIX vs RMFCX

Header iconGSIIX vs RMFCX Comparison
Open Charts GSIIX vs RMFCXBanner chart's image
Goldman Sachs Equity Income Instl
Price$47.08
Change-$0.86 (-1.79%)
VolumeN/A
Net Assets399.64M
American Funds American Mutual R3
Price$56.15
Change-$0.84 (-1.47%)
VolumeN/A
Net Assets104.75B
GSIIX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSIIX vs. RMFCX commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSIIX is a Buy and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 105B vs. GSIIX (400M). GSIIX pays higher dividends than RMFCX: GSIIX (1.55) vs RMFCX (1.37). GSIIX was incepted earlier than RMFCX: GSIIX (29 years) vs RMFCX (23 years). RMFCX (0.91) is less costly to investors than GSIIX (0.84). GSIIX (31.00) and RMFCX (31.00) have comparable annual turnover. RMFCX has a lower initial minimum investment than GSIIX: RMFCX (250) vs GSIIX (1000000). RMFCX annual gain was more profitable for investors over the last year : 5.25 vs. GSIIX (1.44). RMFCX return over 5 years is better than : 59.57 vs. GSIIX (51.06).
GSIIXRMFCXGSIIX / RMFCX
Total Expense Ratio0.700.9177%
Annual Report Gross Expense Ratio0.840.9192%
Fund Existence29 years23 years-
Gain YTD3.0003.18194%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets400M105B0%
Annual Yield % from dividends1.551.37113%
Returns for 1 year1.445.2527%
Returns for 3 years17.3820.4585%
Returns for 5 years51.0659.5786%
Returns for 10 years64.1362.18103%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PLUS65.39-1.11
-1.66%
ePlus
FBIOP6.66-0.16
-2.28%
Fortress Biotech
APPF206.19-7.28
-3.41%
AppFolio
RGNX9.64-0.36
-3.60%
REGENXBIO
ZNTL1.21-0.07
-5.47%
Zentalis Pharmaceuticals